0
0

TREATING SUBSTANCE USE DISORDERSA Quick Reference Guide

DOI: 10.1176/appi.books.9780890423370.145633
text A A A

Sections

Excerpt

Based on Practice Guideline for the Treatment of Patients With Substance Use Disorders, Second Edition, originally published in August 2006. A guideline watch, summarizing significant developments in the scientific literature since publication of this guideline, may be available.

Your session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
 
Username
Password
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Table Reference Number
Table 1. Items to Include in an Assessment
Table Reference Number
Table 2. Treatment Settings
Table Reference Number
Table 3. Individual Patient Characteristics That May Influence Treatment
Table Reference Number
Table 4. Medical Disorders Associated With Specific Substances
Table Reference Number
Table 5. Treatments for Other Co-occurring Psychiatric Disorders in Patients With Substance Use Disorders
Table Reference Number
Table 6. Pharmacological Treatments for Nicotine Dependence
Table Reference Number
TABLE 7. Implementation of Pharmacotherapies for Alcohol-Dependent Patients
Table Reference Number

Level of Intoxication

Indicators

Treatment

Mild to moderate

Drowsiness, pupillary constriction, slurred speech

Specific treatment is usually not required

Severe overdose (may be fatal)

Respiratory depression, stupor, coma

Requires treatment in inpatient or ER setting

May require ventilatory assistance

Use naloxone to reverse

Table Reference Number
Implementation of Methadone, Buprenorphine, or Naltrexone

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Related Content
Articles
Books
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 11.  >
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 26.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 18.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 26.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 16.  >
Topic Collections
Psychiatric News
APA Guidelines
PubMed Articles
Analysis of the medical use of marijuana and its societal implications. J Am Pharm Assoc (Wash) 1998 Mar-Apr;38(2):220-7.
[Pharmacotherapy of substance dependence and withdrawal syndromes]. Ther Umsch 2009;66(6):449-57.doi:10.1024/0040-5930.66.6.449.
 
  • Print
  • PDF
  • E-mail
  • Chapter Alerts
  • Get Citation